260 related articles for article (PubMed ID: 33298146)
1. Design, development, and evaluation of the efficacy of a nucleic acid-free version of a bacterial ghost candidate vaccine against avian pathogenic E. coli (APEC) O78:K80 serotype.
Soleymani S; Tavassoli A; Hashemi Tabar G; Kalidari GA; Dehghani H
Vet Res; 2020 Dec; 51(1):144. PubMed ID: 33298146
[TBL] [Abstract][Full Text] [Related]
2. Bacterial ghost of avian pathogenic E. coli (APEC) serotype O78:K80 as a homologous vaccine against avian colibacillosis.
Ebrahimi-Nik H; Bassami MR; Mohri M; Rad M; Khan MI
PLoS One; 2018; 13(3):e0194888. PubMed ID: 29566080
[TBL] [Abstract][Full Text] [Related]
3. The design and application of a bacterial ghost vaccine to evaluate immune response and defense against avian pathogenic Escherichia coli O2:K1 serotype.
Hoseini Shahidi R; Hashemi Tabar G; Bassami MR; Jamshidi A; Dehghani H
Res Vet Sci; 2019 Aug; 125():153-161. PubMed ID: 31228739
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Iss as a potential vaccine for avian colibacillosis.
Lynne AM; Kariyawasam S; Wannemuehler Y; Johnson TJ; Johnson SJ; Sinha AS; Lynne DK; Moon HW; Jordan DM; Logue CM; Foley SL; Nolan LK
Avian Dis; 2012 Mar; 56(1):192-9. PubMed ID: 22545546
[TBL] [Abstract][Full Text] [Related]
5. Use of a modified bacterial ghost lysis system for the construction of an inactivated avian pathogenic Escherichia coli vaccine candidate.
Hu J; Zuo J; Chen Z; Fu L; Lv X; Hu S; Shi X; Jing Y; Wang Y; Wang Z; Mi R; Huang Y; Liu D; Qi K; Han X
Vet Microbiol; 2019 Feb; 229():48-58. PubMed ID: 30642598
[TBL] [Abstract][Full Text] [Related]
6. Regulated delayed attenuation improves vaccine efficacy in preventing infection from avian pathogenic Escherichia coli O
Han Y; Luo P; Chen Y; Xu J; Sun J; Guan C; Wang P; Chen M; Zhang X; Zhu Y; Zhu T; Zhai R; Cheng C; Song H
Vet Microbiol; 2021 Mar; 254():109012. PubMed ID: 33611126
[TBL] [Abstract][Full Text] [Related]
7. Immunization with outer membrane vesicles of avian pathogenic Escherichia coli O78 induces protective immunity in chickens.
Wang H; Liang K; Kong Q; Liu Q
Vet Microbiol; 2019 Sep; 236():108367. PubMed ID: 31500727
[TBL] [Abstract][Full Text] [Related]
8. A biologically conjugated polysaccharide vaccine delivered by attenuated Salmonella Typhimurium provides protection against challenge of avian pathogenic Escherichia coli O1 infection.
Han Y; Liu Q; Yi J; Liang K; Wei Y; Kong Q
Pathog Dis; 2017 Nov; 75(8):. PubMed ID: 28911037
[TBL] [Abstract][Full Text] [Related]
9. A bivalent vaccine derived from attenuated Salmonella expressing O-antigen polysaccharide provides protection against avian pathogenic Escherichia coli O1 and O2 infection.
Han Y; Liu Q; Willias S; Liang K; Li P; Cheng A; Kong Q
Vaccine; 2018 Feb; 36(8):1038-1046. PubMed ID: 29358057
[TBL] [Abstract][Full Text] [Related]
10. LuxS contributes to virulence in avian pathogenic Escherichia coli O78:K80:H9.
Palaniyandi S; Mitra A; Herren CD; Zhu X; Mukhopadhyay S
Vet Microbiol; 2013 Oct; 166(3-4):567-75. PubMed ID: 23958403
[TBL] [Abstract][Full Text] [Related]
11. A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli.
Van Goor A; Stromberg ZR; Mellata M
PLoS One; 2017; 12(8):e0183929. PubMed ID: 28837660
[TBL] [Abstract][Full Text] [Related]
12. Phylogenetic Analysis of bor Gene in an Escherichia coli Strain 1378 (O78:K80) Isolated from an Avian Colibacillosis Case in Tehran, Iran.
Nayeri Fasaei B; Zahraei Salehi T; Salari S; Ranjbar MM; Yousefi AR
Arch Razi Inst; 2019 Sep; 74(3):313-320. PubMed ID: 31592597
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity in chickens with orally administered recombinant chicken-borne Lactobacillus saerimneri expressing FimA and OmpC antigen of O78 avian pathogenic Escherichia coli.
Ma ST; Ding GJ; Huang XW; Wang ZW; Wang L; Yu ML; Shi W; Jiang YP; Tang LJ; Xu YG; Li YJ
J Med Microbiol; 2018 Mar; 67(3):441-451. PubMed ID: 29458539
[TBL] [Abstract][Full Text] [Related]
14. An attenuated mutant of avian pathogenic Escherichia coli serovar O78: a possible live vaccine strain for prevention of avian colibacillosis.
Nagano T; Kitahara R; Nagai S
Microbiol Immunol; 2012 Sep; 56(9):605-12. PubMed ID: 22708916
[TBL] [Abstract][Full Text] [Related]
15. A Vaccine to Prevent Egg Layer Peritonitis in Chickens.
Cox GJM; Griffith B; Reed M; Sandstrom JD; Peterson MP; Emery D; Straub DE
Avian Dis; 2021 Mar; 65(1):198-204. PubMed ID: 34339140
[TBL] [Abstract][Full Text] [Related]
16. Immune responses associated with homologous protection conferred by commercial vaccines for control of avian pathogenic Escherichia coli in turkeys.
Sadeyen JR; Wu Z; Davies H; van Diemen PM; Milicic A; La Ragione RM; Kaiser P; Stevens MP; Dziva F
Vet Res; 2015 Jan; 46(1):5. PubMed ID: 25613193
[TBL] [Abstract][Full Text] [Related]
17. Genomic avenue to avian colisepticemia.
Huja S; Oren Y; Trost E; Brzuszkiewicz E; Biran D; Blom J; Goesmann A; Gottschalk G; Hacker J; Ron EZ; Dobrindt U
mBio; 2015 Jan; 6(1):. PubMed ID: 25587010
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a live attenuated Escherichia coli O78:K80 vaccine in chickens and turkeys.
La Ragione RM; Woodward MJ; Kumar M; Rodenberg J; Fan H; Wales AD; Karaca K
Avian Dis; 2013 Jun; 57(2):273-9. PubMed ID: 24689185
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of immunogenicity and efficacy of the enterobactin conjugate vaccine in protecting chickens from colibacillosis.
Wang H; Cao L; Logue CM; Barbieri NL; Nolan LK; Lin J
Vaccine; 2023 Jan; 41(4):930-937. PubMed ID: 36585279
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the safety and efficacy of the wild-type and lpxL/lpxM mutant inactivated vaccine against the avian pathogenic Escherichia coli O1, O2, and O78 challenge.
Wu J; Jiang L; Shao Q; Liu J; Wang H; Gao Q; Huan C; Wang X; Gao S
Vaccine; 2024 Apr; 42(10):2707-2715. PubMed ID: 38503663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]